000 | 01162 a2200373 4500 | ||
---|---|---|---|
005 | 20250513235636.0 | ||
264 | 0 | _c20010521 | |
008 | 200105s 0 0 eng d | ||
022 | _a0025-6196 | ||
024 | 7 |
_a10.4065/76.4.353 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElliott, D S | |
245 | 0 | 0 |
_aMedical management of overactive bladder. _h[electronic resource] |
260 |
_bMayo Clinic proceedings _cApr 2001 |
||
300 |
_a353-5 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 | _aAge Distribution |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCholinergic Antagonists _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aUrinary Bladder, Neurogenic _xdiagnosis |
650 | 0 | 4 |
_aUrinary Incontinence, Stress _xdiagnosis |
650 | 0 | 4 |
_aUrination Disorders _xdiagnosis |
700 | 1 | _aLightner, D J | |
700 | 1 | _aBlute, M L | |
773 | 0 |
_tMayo Clinic proceedings _gvol. 76 _gno. 4 _gp. 353-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4065/76.4.353 _zAvailable from publisher's website |
999 |
_c11256421 _d11256421 |